Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Other Working Capital Changes (2022 - 2025)

Historic Other Working Capital Changes for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to $224625.0.

  • Coya Therapeutics' Other Working Capital Changes fell 8025.71% to $224625.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$554062.0, marking a year-over-year decrease of 11067.11%. This contributed to the annual value of $4.9 million for FY2024, which is 22708.83% up from last year.
  • As of Q3 2025, Coya Therapeutics' Other Working Capital Changes stood at $224625.0, which was down 8025.71% from $827695.0 recorded in Q2 2025.
  • In the past 5 years, Coya Therapeutics' Other Working Capital Changes registered a high of $2.0 million during Q2 2024, and its lowest value of -$3.1 million during Q1 2025.
  • Moreover, its 4-year median value for Other Working Capital Changes was $275244.0 (2023), whereas its average is $349545.5.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 223367.44% in 2023, then plummeted by 123509.97% in 2025.
  • Coya Therapeutics' Other Working Capital Changes (Quarter) stood at $1.2 million in 2022, then surged by 51.56% to $1.8 million in 2023, then dropped by 16.17% to $1.5 million in 2024, then tumbled by 85.22% to $224625.0 in 2025.
  • Its Other Working Capital Changes stands at $224625.0 for Q3 2025, versus $827695.0 for Q2 2025 and -$3.1 million for Q1 2025.